Retatrutide, Retatrutide, Retatrutide, Retatrutide, Retatrutide, Placebo Injection clinical trials

J1I-MC-GZBN:A Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants who have Obesity or Overweight and Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Trial

This study looks at a new weekly injection called LY3437943 to see if it helps people with knee osteoarthritis who are also overweight or obese. It aims to reduce knee pain and body weight, comparing the new drug to a dummy injection.